IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
29 hedge funds and large institutions have $48.9M invested in Insight Molecular Diagnostics Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
10
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.46M |
2 |
2
Renaissance Technologies
New York
|
$78.8K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$46.4K |
4 |
4
BlackRock
New York
|
$261K |
5 |
EWA
5
EverSource Wealth Advisors
Birmingham,
Alabama
|
$15.1K |